Related references
Note: Only part of the references are listed.PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism
Aileen A. Ren et al.
NATURE (2021)
Postzygotic mosaicism in cerebral cavernous malformation
Matthias Rath et al.
JOURNAL OF MEDICAL GENETICS (2020)
Human endothelial cells size-select their secretory granules for exocytosis to modulate their functional output
Jessica J. McCormack et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Fibronectin rescues aberrant phenotype of endothelial cells lacking either CCM1, CCM2 or CCM3
Konrad Schwefel et al.
FASEB JOURNAL (2020)
Cerebral cavernous malformations are driven by ADAMTS5 proteolysis of versican
Courtney C. Hong et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Endothelial characteristics in healthy endothelial colony forming cells; generating a robust and valid ex vivo model for vascular disease
Suzan de Boer et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Cerebral Cavernous Malformation: What a Practicing Clinician Should Know
Kelly D. Flemming et al.
MAYO CLINIC PROCEEDINGS (2020)
Modulation of endothelial organelle size as an antithrombotic strategy
Francesco Ferraro et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Precise CCM1 gene correction and inactivation in patient-derived endothelial cells: Modeling Knudson's two-hit hypothesis in vitro
Stefanie Spiegler et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2019)
Variability of von Willebrand factor-related parameters in endothelial colony forming cells
Annika de Jong et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Endothelial cell clonal expansion in the development of cerebral cavernous malformations
Matteo Malinyerno et al.
NATURE COMMUNICATIONS (2019)
Long-term antithrombotic therapy and risk of intracranial haemorrhage from cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis
Susanna M. Zuurbier et al.
LANCET NEUROLOGY (2019)
Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice
Miguel Alejandro Lopez-Ramirez et al.
BLOOD (2019)
Biallelic CCM3 mutations cause a clonogenic survival advantage and endothelial cell stiffening
Konrad Schwefel et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Exocytosis of Weibel-Palade bodies: how to unpack a vascular emergency kit
M. Schillemans et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Consensus guidelines for the use and interpretation of angiogenesis assays
Patrycja Nowak-Sliwinska et al.
ANGIOGENESIS (2018)
Expansion of functional personalized cells with specific transgene combinations
Christoph Lipps et al.
NATURE COMMUNICATIONS (2018)
Cerebral Cavernous Malformations Develop Through Clonal Expansion of Mutant Endothelial Cells
Matthew R. Detter et al.
CIRCULATION RESEARCH (2018)
Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel
Amy Akers et al.
NEUROSURGERY (2017)
KLF4 is a key determinant in the development and progression of cerebral cavernous malformations
Roberto Cuttano et al.
EMBO MOLECULAR MEDICINE (2016)
Top ten research priorities for brain and spine cavernous malformations
Rustam Al-Shahi Salman et al.
LANCET NEUROLOGY (2016)
Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data
Margaret A. Horne et al.
LANCET NEUROLOGY (2016)
Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling
Zinan Zhou et al.
NATURE (2016)
Weibel-Palade body size modulates the adhesive activity of its von Willebrand Factor cargo in cultured endothelial cells
Francesco Ferraro et al.
SCIENTIFIC REPORTS (2016)
Regulation of β1 Integrin-Klf2-Mediated Angiogenesis by CCM Proteins
Marc Renz et al.
DEVELOPMENTAL CELL (2015)
Endothelial cell spheroids as a versatile tool to study angiogenesis in vitro
Maximilian Heiss et al.
FASEB JOURNAL (2015)
Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations
Robert Shenkar et al.
GENETICS IN MEDICINE (2015)
A Two-Tier Golgi-Based Control of Organelle Size Underpins the Functional Plasticity of Endothelial Cells
Francesco Ferraro et al.
DEVELOPMENTAL CELL (2014)
Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis
David A. McDonald et al.
HUMAN MOLECULAR GENETICS (2014)
Analysis of the storage and secretion of von Willebrand factor in blood outgrowth endothelial cells derived from patients with von Willebrand disease
Jiong-Wei Wang et al.
BLOOD (2013)
CCM1-ICAP-1 complex controls β1 integrin-dependent endothelial contractility and fibronectin remodeling
Eva Faurobert et al.
JOURNAL OF CELL BIOLOGY (2013)
The secretion of von Willebrand factor from endothelial cells; an increasingly complicated story
T. Nightingale et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
EndMT contributes to the onset and progression of cerebral cavernous malformations
Luigi Maddaluno et al.
NATURE (2013)
Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study
Rustam Al-Shahi Salman et al.
LANCET NEUROLOGY (2012)
The Shear Stress-Induced Transcription Factor KLF2 Affects Dynamics and Angiopoietin-2 Content of Weibel-Palade Bodies
Ellen L. van Agtmaal et al.
PLOS ONE (2012)
Antithrombotic Therapy and Bleeding Risk in a Prospective Cohort Study of Patients With Cerebral Cavernous Malformations
Hans-Martin Schneble et al.
STROKE (2012)
Impairment of Tight Junctions and Glucose Transport in Endothelial Cells of Human Cerebral Cavernous Malformations
Hannah Schneider et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells
Axel Pagenstecher et al.
HUMAN MOLECULAR GENETICS (2009)
Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis
Amy L. Akers et al.
HUMAN MOLECULAR GENETICS (2009)
von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)
W. L. Nichols et al.
HAEMOPHILIA (2008)
Hemorrhage From Cavernous Malformations of the Brain Definition and Reporting Standards
Rustam Al-Shahi Salman et al.
STROKE (2008)
KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell-cell junctions
Angela Glading et al.
JOURNAL OF CELL BIOLOGY (2007)
Rate, extent and concentration dependence of histamine-evoked Weibel-Palade body exocytosis determined from individual fusion events in human endothelial cells
A. Erent et al.
JOURNAL OF PHYSIOLOGY-LONDON (2007)
KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium
Rob J. Dekker et al.
BLOOD (2006)
Dynein-dynactin complex mediates protein kinase A-dependent clustering of Weibel-Palade bodies in endothelial cells
MG Rondaij et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Thrombus and encapsulated hematoma in cerebral cavernous malformations
M Abe et al.
ACTA NEUROPATHOLOGICA (2005)
Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion
J Gault et al.
STROKE (2005)
Share Paper
